In ovarian cancer, HSD17B12 silencing significantly inhibited tumor cell proliferation, while exogenous arachidonic acid restored the growth inhibitory effect, suggesting its function depends on the reductase activity [29]. Here, HSD17B12 is linked to neoplasm.